A carregar...
Specific CDK4/6 inhibition in breast cancer: a systematic review of current clinical evidence
BACKGROUND: Loss of cell cycle control is a hallmark of cancer, and aberrations in the cyclin-dependent kinase-retinoblastoma (CDK-Rb) pathway are common in breast cancer (BC). Consequently, inhibition of this pathway is an attractive therapeutic strategy. The present review addresses efficacy and t...
Na minha lista:
| Publicado no: | ESMO Open |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
ESMO Open
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5419212/ https://ncbi.nlm.nih.gov/pubmed/28848657 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/esmoopen-2016-000093 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|